Fluoxetine, a commonly used antidepressant, has been documented to lower serum levels of inflammatory markers including IL‐1β, IL‐6, and TNF‐α (Mojiri‐Forushani et al., 2023), suggesting that inhibition of inflammation could attenuate depression. The gene discussed is IL6; the disease is major depressive disorder.